Skip to main content
Total Market Cap: $47,645,390,035 Volume (24h): $898,814,384

Canntab Therapeutics Limited

Canntab Therapeutics Limited (PILL) logo
Rank 122
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Website
$0.2330
USD
7.14%
Market cap
$8,261,170
Total volume
$2,926
Shares outstanding
35,451,437
Reserved shares
16,510,036
Rank 122
Website
About

Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
The Canadian Securities Exchange
CSE
PILL
$116
3.96%
$0.2330
OTC
CTABF
Total volume
$2,810
96.04%
Stock price
$0.6160
Chart
Social media
Tweets by @@Canntab_
Canntab Therapeutics Limited

Share widget

Copy widget code
Subscribe to our newsletter